Antithrombin Market: By Source (Goat Milk, Human, Others), By Application (Diagnostics, Therapeutics, Research), By Dosage Form (Liquid, Lyophilized), By End User (Blood Banks, Diagnostic Centres, Hospitals), and Geography       

Purchase Option

$ 4400
$ 6600
$ 8900

Antithrombin Market size was valued at USD 510.13 million in 2022, growing at a CAGR of 5.2% from 2023-2029. Antithrombin is protein molecule which inactivates various enzymes of coagulation system. It is produced by liver, consists of 432 amino acids. It consists of three disulphide bonds and four glycosylation sites. ?-Antithrombin is most common antithrombin form found in blood plasma. Antithrombin shows synergistic activity with heparin, that enhances the antithrombin binding with Thrombin (factor II a) and Factor Xa. Wide range of antithrombin applications for various medical conditions like disseminated intravascular coagulation, hereditary antithrombin deficiency, extracorporeal membrane oxygenation, and increased clinical significance of engineered antithrombin in the prevention of late peripartum and perioperative blood clots are expected to drive the revenue There growth of  antithrombin market across the globe. Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, Furthermore, increase in prevalence of blood clotting-related disorders and, the growing geriatric population is expected to propel the antithrombin market. However, the high cost of antithrombin products, lack of awareness, and risks related with blood and blood-related products expected to dampen the growth of Antithrombin market. In April 2014, Revo Biologics started preserve 1 phase III clinical trials of ATryn (recombinant antithrombin) for the treatment of preeclampsia in pregnant women during the 24th to 28th weeks of pregnancy.

Antithrombin Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

5.2%

Largest Market

North America

Fastest Growing Market

Europe
Antithrombin Market Dynamics

Rise in usage of heparin and antithrombin combination is the major driving factor for the growth of antithrombin market. For example, heparin resistance cardiac surgery is providing many opportunities for use of antithrombin product in anticoagulation therapy. Antithrobin market is highly consolidated owing to the presence of well-established players. The market is dominated by few players with large economic share. Market players focused on many growth strategies like mergers and acquisitions, new product launches to increase the product portfolio, to strengthen geographical presence.

Antithrombin Market Segmentation

By Source
  • Goat Milk
  • Human
  • Others
By Application
  • Diagnostics
  • Therapeutics
  • Research
By Dosage Form
  • Liquid
  • Lyophilized
By End User
  • Blood Banks
  • Diagnostic Centres
  • Hospitals

Frequently Asked Questions

The antithrombin market size was valued at USD 510.13 million in 2022

The antithrombin market key players are: Grifols (Spain) rEVO Biologics, Inc. (U.S.) Kedrion S.p.A (Italy) CSL Limited (Australia) Scripps Laboratories, Inc. (U.S.) Lee Bisolutions, Inc. (U.S.) Dem ilac, Inc. (U.S.) Diapharma Group, Inc.(U.S.) Octapharma AG (Switzerland)

The antithrombin market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
1. Executive Summary
2. Global Antithrombin Market Introduction 
2.1.Global Antithrombin Market  - Taxonomy
2.2.Global Antithrombin Market  - Definitions
2.2.1.Source
2.2.2.Application
2.2.3.Dosage Form
2.2.4.End User
2.2.5.Region
3. Global Antithrombin Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Global Antithrombin Market Analysis, 2018 - 2022 and Forecast 2023 - 2029
4.1.  Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Global Antithrombin Market  By Source, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
5.1. Goat Milk
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Human
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Others
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
6. Global Antithrombin Market  By Application, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
6.1. Diagnostics
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Therapeutics
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Research
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
7. Global Antithrombin Market  By Dosage Form, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
7.1. Liquid
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Lyophilized
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
8. Global Antithrombin Market  By End User, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
8.1. Blood Banks
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Diagnostic Centres
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Hospitals
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
9. Global Antithrombin Market  By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
9.1. North America
9.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Europe
9.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Asia Pacific (APAC)
9.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Middle East and Africa (MEA)
9.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Latin America
9.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
10. North America Antithrombin Market,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
10.1. Source Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Goat Milk
10.1.2.Human
10.1.3.Others
10.2.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Diagnostics
10.2.2.Therapeutics
10.2.3.Research
10.3.  Dosage Form Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Liquid
10.3.2.Lyophilized
10.4.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Blood Banks
10.4.2.Diagnostic Centres
10.4.3.Hospitals
10.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1.United States of America (USA)
10.5.2.Canada
11. Europe Antithrombin Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
11.1. Source Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Goat Milk
11.1.2.Human
11.1.3.Others
11.2.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Diagnostics
11.2.2.Therapeutics
11.2.3.Research
11.3.  Dosage Form Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Liquid
11.3.2.Lyophilized
11.4.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Blood Banks
11.4.2.Diagnostic Centres
11.4.3.Hospitals
11.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
11.5.6.Rest of EU
12. Asia Pacific (APAC) Antithrombin Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
12.1. Source Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Goat Milk
12.1.2.Human
12.1.3.Others
12.2.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Diagnostics
12.2.2.Therapeutics
12.2.3.Research
12.3.  Dosage Form Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Liquid
12.3.2.Lyophilized
12.4.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Blood Banks
12.4.2.Diagnostic Centres
12.4.3.Hospitals
12.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13. Middle East and Africa (MEA) Antithrombin Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
13.1. Source Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Goat Milk
13.1.2.Human
13.1.3.Others
13.2.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Diagnostics
13.2.2.Therapeutics
13.2.3.Research
13.3.  Dosage Form Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Liquid
13.3.2.Lyophilized
13.4.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Blood Banks
13.4.2.Diagnostic Centres
13.4.3.Hospitals
13.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.GCC Countries
13.5.2.South Africa
13.5.3.Rest of MEA
14. Latin America Antithrombin Market,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
14.1. Source Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.Goat Milk
14.1.2.Human
14.1.3.Others
14.2.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.Diagnostics
14.2.2.Therapeutics
14.2.3.Research
14.3.  Dosage Form Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Liquid
14.3.2.Lyophilized
14.4.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Blood Banks
14.4.2.Diagnostic Centres
14.4.3.Hospitals
14.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Brazil
14.5.2.Mexico
14.5.3.Rest of LA
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.Grifols (Spain)
15.2.2.rEVO Biologics, Inc. (U.S.)
15.2.3.Kedrion S.p.A (Italy)
15.2.4.CSL Limited (Australia)
15.2.5.Scripps Laboratories, Inc. (U.S.)
15.2.6.Lee Bisolutions, Inc. (U.S.)
15.2.7.Dem ilac, Inc. (U.S.)
15.2.8.Diapharma Group, Inc.(U.S.)
15.2.9.Octapharma AG (Switzerland)
16. Research Methodology 
17. Appendix and Abbreviations 

 

  • Grifols (Spain)
  • rEVO Biologics, Inc. (U.S.)
  • Kedrion S.p.A (Italy)
  • CSL Limited (Australia)
  • Scripps Laboratories, Inc. (U.S.)
  • Lee Bisolutions, Inc. (U.S.)
  • Dem ilac, Inc. (U.S.)
  • Diapharma Group, Inc.(U.S.)
  • Octapharma AG (Switzerland)

Adjacent Markets